Given its widespread involvement in various cancers, PVT1 has potential as a biomarker for diagnosis and prognosis. Elevated levels of PVT1 in tissues and blood samples have been correlated with poor patient outcomes in several cancers. However, more research is needed to validate its utility as a reliable biomarker across different types of cancer.
